Skip to main content

Catherine Watson, MD

watson
Start Year: 
2018

Why did you choose Duke for your fellowship training?

I chose Duke because I wanted to train with a group of compassionate gynecologic oncologists with varied research interests who could provide strong academic and clinical mentorship. This opportunity, along with the university’s extensive resources and collaborative academic community, made Duke the best fit for my fellowship goals.

 

What are your career goals?

Ultimately, I plan to work in academics and contribute to the field through teaching and research, while maintaining an active clinical practice.

 

What are your hobbies?

In my free time, I enjoy spending time with my husband, going on runs and hikes with my dog, reading, and playing piano.

 

Education & Training

Undergraduate school & graduation year:

Yale University 2010

Medical school & graduation year:

Medical University of South Carolina 2014

Residency & graduation year

University of Tennessee 2018

 

Awards and Honors

 

  • OB/GYN Administrative Chief Resident (University of Tennessee, 2017-2018) 
  •  Gold Humanism and Excellence in Teaching Award (University of Tennessee, 2016) 
  • AAGL Outstanding Laparoscopist Award (University of Tennessee, 2016)

 

Publications & Presentations

 

Watson CH, Ulm M, Blackburn P, Smiley L, Covington R, Bokovtiz L.Tillmanns T. “Video-assisted genetic counseling in patients with ovarian, fallopian and peritoneal cancer.” Gynecol Oncol.. 2016 Oct;143(1):109-12. 

Ulm,M., Watson CH, Vaddadi, P, Wan J, Santoso J. “Hypomagnesemia is prevalent in patients undergoing surgery for gynecologic malignancy.” Int J Gynecol Cancer. 2016 Sept ;26 (7):1320-1326. 

Neal, S, Graybill W, Garrett-Mayer E, McDowell M, McLean V, Watson C, Y Pierce J, Kohler M, Creasman W. “Lymphovascular space invasion in uterine corpus cancer: what is its prognostic significance in the absence of lymph node metastases?” Gynecol Oncol. 2016 Aug; 142 (2):278-82. 

Haar CP, Swift S. “The prevention of cervical cancer in developing nations.” J SC Med Assoc. 2013 Dec; 109 (4):132-4.  

Wallace G, Haar CP, Mittendorf A, Giglio P, Ray SR, Patek SJ, Vandergrift W, Das A. “Targeting Oncogenic ALK and MET: A promising therapeutic strategy for glioblastoma.” Metabolic Brain Disease. 2013 Sept: 28 (3): 355-66. 

Wallace GC, Haar CP, Vandergrift WA, Giglio P, Dixon-Mah YN, Varma AK, Ray SK, Patel SJ. “Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenograftts in SCID mice via HDAC inhibition.” J Neurooncol. 2013 Aug 114(1):43-50.  

Haar, CP, Hebbar P, Wallace GC 4th, Das A, Vandergrift WA 3rd, Smith JA, Giglio P, Patel SJ, Ray SK, Banik NL. “Drug resistance in glioblastoma; a mini review.” Neurochem Res. 2012 Jun: 37(6): 1192-200.

Research Interests

Describe your research interests/goals:

My research interests include hereditary gynecologic cancers, cancer prevention strategies, healthcare disparities and palliative care.